Regulatory News
Friday, June 17, 2016
BRIEF-Ariad initiates submission of NDA for Brigatinib to FDA ahead of plan
* Rolling NDA submission is expected to be complete in Q3 of
2016.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment